Introduction
Every year millions of cardiac surgeries are performed worldwide. Due to pre-existing coronary artery disease and clamping of coronary artery during surgery, the heart is inevitably subjected to ischaemia/reperfusion (I/R) injury. Perioperative myocardial I/R injury has been identified as the leading cause of morbidity and mortality in cardiac surgery. 1 Reduction of myocardial I/R injury benefits numerous patients receiving cardiac surgery. Volatile anaesthetics such as isoflurane (ISO), sevoflurane, enflurane, and desflurane are used to maintain the state of general anaesthesia during cardiac surgery. 2 Clinical and experimental studies indicate that volatile anaesthetics attenuate myocardial I/R injury, when administered prior to ischaemia. [3] [4] [5] [6] This phenomenon is similar to ischaemic preconditioning, termed anaesthetic preconditioning. 7, 8 Previous studies indicate that anaesthetic preconditioning is triggered and mediated by endothelial nitric oxide synthase (eNOS)-derived nitric oxide (NO). 8, 9 However, the molecular mechanisms underlying the regulation of eNOS by volatile anaesthetics remain unclear. Vascular endothelial growth factor (VEGF) is an angiogenic factor predominantly expressed in vascular endothelium. 10 The VEGF promotes endothelial cell (EC) proliferation, migration, and differentiation in vitro and angiogenesis in vivo. [11] [12] [13] These effects of VEGF are largely dependent on the activation of eNOS. 14 A study from our laboratory found that VEGF was up-regulated by ISO preconditioning. 15 Multiple lines of evidence indicate that VEGF regulates the phosphorylation or dephosphorylation of eNOS, [16] [17] [18] [19] ISO-elicited up-regulation of VEGF might alter phosphorylation of eNOS and the production of NO. Accordingly, the objective of this study was to examine the role of VEGF in regulation of eNOS phosphorylation in ISO-induced cardioprotection against I/R injury.
Methods

Animals
Male Wistar rats (weight 300-400 g; age 10-12 weeks) and pregnant female Wistar rats (age 9-12 weeks) were purchased from Charles River Laboratories International. Inc. (Wilmington, MA, USA). The animals were kept on a 12 h light-dark cycle in a temperature-controlled room.
The experimental procedures were approved by the Animal Care and Use Committee of the Medical College of Wisconsin and conformed to the Guide for the Care and Use of Laboratory Animals (Institute for Laboratory Animal Research, National Academy of Sciences, USA, 8th edition, 2011).
Myocardial I/R injury in vivo
Surgical preparation
We have previously described the rat in vivo model of myocardial I/R injury. 20, 21 Briefly, sodium thiobutabarbital (150 mg/kg, i.p.)-anaesthetized rats were ventilated with room air supplemented with 100% oxygen. The right carotid artery and the left jugular vein were cannulated with heparin-filled catheters for continuous measurement of arterial blood pressure and fluid or drug administration, respectively. A left thoracotomy was performed at the 4th intercostal space, and the heart was suspended in a pericardial cradle. 20 Myocardial ischaemia was produced by occluding the left anterior descending coronary artery, and reperfusion was initiated by loosening the snare. Area at risk (AAR) and infarct size were delineated by intravenous injection of patent blue dye and incubation of myocardium at risk with 2,3,5-triphenyltetrazolium chloride (Sigma-Aldrich, St. Louis, MO, USA), respectively. Arterial blood gas tensions, acid-base status, and body temperature were monitored and maintained within a physiological range throughout the experiment.
Experimental protocol
Wistar rats were randomly assigned to the following six experimental groups (6-9 rats/group): control (CON), ISO, neutralizing antibody against VEGF (nVEGF), nVEGF þ ISO, IgG, and IgG þ ISO ( Figure 1A) . After instrumentation was completed, all rats were stabilized for 30 min and subjected to 30 min of coronary occlusion followed by 2 h of reperfusion. ISO at a concentration of 1.4% was administered via an ISO-specific vaporizer (Ohio Medical Instruments, Madison, WI, USA) for 30 min followed by a period of 15 min washout prior to coronary artery occlusion. Rats in CON, nVEGF, and IgG groups received no ISO. To study the role of VEGF in the cardioprotective effect of ISO, rats were injected intravenously with a bolus of the rat antibody against VEGF (affinity purified goat IgG, 0.3 mg/kg) (R&D, Minneapolis, MN, USA) or goat IgG (0.3 mg/kg) as control 60 min before coronary artery occlusion.
Endothelial cell-cardiomyocyte coculture
Human coronary artery ECs (Cell Applications, San Diego, CA, USA) were cultured in MesoEndo cell growth medium (Cell Applications) and used at 4th passage when reaching 80-90% confluent. 22 Cardiomyocytes (CMs) were isolated from hearts of 1-to 2-day-old Wistar rats, as described. 23 Briefly, animals were anaesthetized with 100% carbon dioxide and sacrificed by cervical dislocation. The heart was removed, washed in ice-cold phosphate buffered saline (pH 7.4 20 min at 100 rpm. 22 The supernatant was collected and centrifuged at 1000 Âg for 6 min, and the pellet was collected in 1 mL of calf serum.
The procedure was repeated till all heart tissue was completely digested. The pellet from each digestion was collected in 30 mL Dulbecco's modified DMEM medium containing 17% medium 199, 10% horse serum, 5% foetal bovine serum, 0.5% penicillin-streptomycin and 20 mM HEPES (pH 7.4) with 100 lM proliferation inhibitor bromodeoxyuridine (Sigma Aldrich). CMs were used 3-5 days after isolation when demonstrating rhythmic contractions. ECs were pre-cultured for 72 h, mixed with CMs at a ratio of 1:6, and cultured in MesoEndo cell growth medium for 12 h, as described. Culture medium was subsequently replaced, and the cells were exposed to 2 h of hypoxia (0.1% O 2 , Biospherix hypoxia chamber, Lacona, NY, USA) in glucose-free DMEM medium followed by 2 h of reoxygenation. The release of lactate dehydrogenase (LDH) into the culture medium as a marker of cell damage was quantified with a commercially available kit (Genzyme Diagnostics, Cambridge, MA, USA). 22 
Effect of VEGF inactivation on I/R injury in EC-CM co-culture
To investigate the role of VEGF in ISO-induced CM protection, cocultured ECs, and CMS were assigned to the following eight experimental groups (n = 6): normoxia, CON, ISO, nVEGF, nVEGF þ ISO, IgG, IgG þ ISO, and L-N G -monomethyl arginine (L-NMMA, an inhibitor of nitric oxide synthase) þ ISO ( Figure 1B) . ECs and CMS were co-cultured for 12 h and subsequently treated with 5 mg/mL nVEGF, 5 mg/mL IgG, 1 mM L-NMMA, or vehicle for 60 min prior to administration of ISO. All cells, except normoxic group, were exposed to hypoxia for 2 h followed by 2 h of reoxygenation.
Immunoblotting
Total soluble protein from cell lysates was prepared, as previously described. 22 
Ozone chemiluminescence
The concentration of NO was measured as the amount of nitrite formed when NO reacts with oxygen using iodide and acetic acid at room temperature by using a Sievers NO gas analyser (Model 280, GE Analytical Instruments, Boulder, CO, USA), as described. 24, 25 Briefly, 1 mL of medium sample was taken 60 min after ISO exposure (control medium was collected at the same time) as basal NO production. Thirty microlitre of medium was sampled in NO gas analyser, and nitrite concentration was calculated after subtraction of background of MesoEndo cell growth medium and normalized to total cell proteins from cell lysates.
Generation of HIF1a short hairpin RNA
Lentiviral particles containing HIF1a short hairpin RNA (shRNA) and its scrambled sequence were produced, as described. 26 Briefly, 10 lg HIF1a or CON shRNA plasmid, 6.5 lg porcine cytomegalovirus (p-CMV) R8.74 as packing construct, and 3.5 lg vesicular stomatitis virus glycoprotein-G (VSV-G) carrying the sequence for the envelope, were co-transfected into 293T cells using the calcium-phosphate co-precipitation method. Media were replaced after 12-14 h. After 36-48 h, the replication-defective lentiviral vectors were harvested, cleared by lowspeed centrifugation and filtered through 0.45 lm cellulose acetate filters. The viral titer was determined by FACS analysis of GFP-positive 293T cells. Pilot experiments using a GFP expressing lentiviral vector were performed to determine the optimal multiplicity of infection and were found to be 10 (95-100% GFP-positive EC). ECs were infected with HIF1a shRNA or scramble shRNA at a dose of 4 Â 10 5 transducing unit per well in 24-well plate for three consecutive days when it reached 50-60% confluency.
Effects of VEGF knockdown with HIF1a short hairpin RNA on the cardioprotective effect of ISO in vitro
The effects of HIF1a knockdown in ECs on ISO-induced CM protection were studied in EC-CM co-culture divided into eight experimental groups (n = 6): CON, ISO, shRNA, shRNA þ ISO, SCR, SCR þ ISO, shRNA þ recombinant VEGF (rVEGF), and shRNA þ rVEGF þ ISO ( Figure 1C) . ECs in shRNA, shRNA þ ISO, SCR, SCR þ ISO, shRNA þ rVEGF, and shRNA þ rVEGF þ ISO groups were infected with HIF1a shRNA or scramble shRNA for 72 h, whereas ECs in CON and ISO groups underwent all culture procedures without shRNA or scramble sHRNA infection. ECs and CMs were co-cultured for 12 h and subjected to 2 h of hypoxia followed by 2 h of reoxygenation. ISO was administered for 60 min via an ISO-specific vaporizer (Ohio Medical Instruments) prior to hypoxia, and the ISO concentration was monitored by a gas analyser (POET IQ, Criticare System, Waukesha, WI, USA). In some experiments, human recombinant VEGF 165 (rVEGF) (Calbiochem, San Diego, CA, USA) at a final concentration of 100 ng/mL was added into the cultured cells at the start of the co-culture. The release of LDH into the media was determined at the conclusion of reoxygenation.
Statistics
All data are expressed as mean ± standard error of mean (SEM). Kruskal-Wallis test followed by Dunn's test was used to analyse multiple group comparisons. Repeated-measures analysis of variance followed by Bonferroni multiple comparison test was used to evaluate differences in heart rate and mean arterial blood pressure. All statistical analyses were performed using GraphPad Prism 6 (GraphPad Software, Inc.). A twotailed P-value of <0.05 was considered statistically significant.
Results
ISO-induced decrease in infarct size was blocked by VEGF inactivation in rats
Heart rate and mean arterial blood pressure during in vivo rat experiment were listed in Table 1 . There were no significant differences in both heart rate and mean arterial blood pressure at baseline among six experimental groups (n = 6-9 rats/group): CON, ISO, nVEGF, nVEGF þ ISO, IgG, and IgG þ ISO. Coronary artery occlusion did not significantly change heart rate in all groups but decreased mean arterial blood pressure in nVEGF þ ISO and IgG þ ISO groups in comparison with baseline blood pressure. In all six groups, mean arterial blood pressure was significantly lower at 60 and 120 min after reperfusion as compared to the baseline (P < 0.05). AAR and myocardial infarct size in rat experiment are shown in Figure 2 . There were no significant differences in AAR among the six experimental groups (Figure 2A) . Coronary occlusion followed by reperfusion resulted in infarct size of 60 ± 1% of AAR (n = 8 rats/group) in control rats, which was significantly decreased to 40 ± 3% (n = 8 rats/ group, P < 0.05) by ISO ( Figure 2B) . Neither nVEGF nor IgG itself significantly changed infarct size compared with CON. ISO-induced decrease in infarct size was blocked by nVEGF (n = 6 rats/group, P < 0.05) but not IgG ( Figure 2B ). Figure 3 demonstrates LDH activity in CMs, ECs, and co-cultured ECs and CMs. Hypoxia/reoxygenation significantly increased LDH activity in both CMs and co-cultured CMs and ECs but not ECs. ISO pre-treatment significantly decreased LDH activity in co-cultured CMs and ECs (n = 6, P < 0.05 vs. CON) ( Figure 3C ) but not in either CMs or ECs ( Figures 3A  and B) after hypoxia/reoxygenation injury. Neither nVEGF nor IgG significantly changed LDH activity in co-cultured CMs and ECs compared with CON group. ISO-induced decrease in LDH activity was blocked by either nVEGF or L-NMMA but not IgG ( Figure 3C ).
VEGF inactivation blocked ISO-induced CM protection in vitro
VEGF inactivation decreased ISOinduced increase in NO production
The pre-treatment of ECs and co-cultured ECs and CMs with ISO resulted in a significant increase in NO production ( Figure 4) . This increase in NO production was not significantly altered by either IgG or scrambled HIF1a shRNA sequence (n = 5, P > 0.05). nVEGF, L-NMMA, HIF1a shRNA did not significantly affect NO production but blocked ISO-induced increases in NO production from ECs and co-cultured ECs and CMs (n = 5, P < 0.05).
VEGF inactivation reduced ISOinduced increase in p-eNOS in ECs
As shown in Figures 5A and B, the ratios of p-Akt/Akt and p-eNOS/ eNOS in ECs were significantly increased by ISO. The pre-treatment of ECs with nVEGF significantly decreased ISO-induced increases in the ratios of p-Akt/Akt and p-eNOS/eNOS (n = 4). In contrast, IgG pretreatment did not significantly change ISO-induced increases in the ratio of pAkt/Akt and p-eNOS/eNOS. Furthermore, the Akt inhibitor, wortmannin (WM), was used to determine if Akt was involved in eNOS phosphorylation by VEGF. WM did not affect the NO production in ECs but blocked the ISO-induced increases in NO ( Figure 5C ).
HIF1a short hairpin RNA downregulated VEGF and VEGFR2 in ECs
The expression of VEGF and VEGFR2 proteins was not significantly altered in ECs infected with scrambled HIF1a shRNA sequence compared with CON (n = 5, P > 0.05) ( Figure 6 ). In contrast, the expression of both VEGF and its receptor proteins was significantly decreased in ECs infected with lentiviral vector expressing the HIF1a shRNA compared with CON and the scrambled HIF1a shRNA sequence (n = 5, P < 0.05).
HIF1a short hairpin attenuated the protective effect of ISO on CMs
EC infection with lentiviral vector expressing the HIF1a shRNA results in 80-90% decrease in the expression of HIF1a protein (n = 5, P < 0.05 vs. CON) ( Figure 7A ). Neither HIF1a shRNA nor scrambled HIF1a shRNA sequence significantly altered LDH activity in co-cultured CMs and ECs subjected to hypoxia/reoxygenation injury ( Figure 7B) . The treatment of co-cultured ECs and CMs with ISO caused a significant decrease in LDH activity (n = 6, P < 0.05). This protective effect of ISO was abolished by HIF1a shRNA (n = 6, P < 0.05) but not scrambled HIF1a shRNA sequence. The detrimental effect of HIF1a shRNA was restored by rVEGF administered prior to CM-EC co-culture ( Figure 7B ).
Discussion
The results of the present study demonstrate that ISO attenuates myocardial I/R injury in rats and in co-cultured ECs and CMs when administered prior to either I/R or hypoxia/reoxygenation injury. These protective effects of ISO are associated with increases in p-eNOS and protection of NO. Interestingly, either VEGF inactivation or knockdown with HIF1a shRNA in ECs blocks these beneficial effects of ISO. These results not only suggest involvement of the interaction between ECs and CMs in ISO cardiac preconditioning but also indicate the role of VEGFregulated phosphorylation of eNOS in the cardioprotective effect of ISO. We showed that ISO decreased infarct size in rats when applied for 30 min prior to myocardial ischaemia. This result is consistent with previous studies by Baotic et al. 20 Myocardial infarct size reflects the degree of severity of I/R injury. 27 Thus, ISO administered prior to ischaemia potently reduces myocardial I/R injury. The treatment of rats with IgG antibody prior to myocardial ischaemia neither altered AAR and infarct size nor impacted ISO-induced decreases in infarct size. Intriguingly, VEGF is improtant in ISO-induced cardioprotection against I/R injury in rats.
In the heart, CMs are intimately related to ECs in a web-like network of capillaries. 30 Communication between ECs and CMs is important in maintaining physiological regulation of CMs by releasing multiple paracrine factors. 30, 31 In the present study, ISO pretreatment promotes CM survival in co-cultured ECs and CMs but not CMs or ECs alone following hypoxia/reoxygenation injury. These results suggest that EC-CM interaction plays an important role in ISO-induced CM protection from hypoxia/reoxygenation injury. It has been known that in response to ischaemia and reperfusion, either ECs or CMs produce and release multiple endogenous mediators such as NO, reactive oxygen species, adenosine, cyclic ADP-ribose, opioids, neuregulin, and succinate. 22, 24, 32, 33 These mediators possess strong biological effects on adjacent cells and can alter cell survival and injury. [34] [35] [36] [37] Thus, interactions between ECs and CMs are involved in ISO-induced cardioprotection against I/R injury. The current study demonstrated that ISO increased the phosphorylation of eNOS in ECs. These results are consistent with previous studies by Baotic et al. 20 and Qiao et al. 6 Intriguingly, this beneficial effect of ISO on eNOS was blocked by VEGF inactivation. Furthermore, our study shows that VEGF binds to its receptors, VEGFR2 (KDR/Flk-1), which induces the phosphorylation of AKT and eNOS. These results are consistent with previous studies. 38, 39 Taken together, VEGF plays an Phosphorylation of eNOS modulates the production of NO. 40, 41 In ECs alone or co-cultured ECs and CMs, ISO elevated the production of NO, whereas either VEGF inactivation or knockdown blocked the favourable effect of ISO on NO. It is clear that NO derived from eNOS acts as a paracrine factor to trigger the cardioprotective effect of ISO. 42 Thus, VEGF may mediate the production of NO. We demonstrated that HIF1a shRNA decreased the expression of not only HIF1a but also VEGF in ECs. HIF1a is a key regulator responsible for the induction of genes that facilitate the adaptation and survival of cells from normoxia to hypoxia. 43, 44 Previous studies by Wang et al. 15 and Leucker et al. 42 reports that the expression of HIF1a protein in rat hearts or cultured CMs is significantly enhanced following ISO treatment. HIF1a has a general role in multiple physiological responses to ischaemia or hypoxia such as energy metabolism, iron homeostasis, vascular remodelling, cell proliferation, and angiogenesis via activating numerous target genes. 45 Interestingly, HIF1a shRNA also decreased the expression of VEGF and VEGFR2 in ECs, suggesting that VEGF is a downstream mediator of HIF1a. It is likely that HIF1a shRNA decreases the expression of VEGF and VEGFR2 through inhibiting their RNAs.
We have previously demonstrated that co-culture of CMs with ECs can mimic myocardial I/R injury in vivo. 22 Indeed, hypoxia/reoxygenation resulted in significant cell injury (increased LDH activity) in co-culture of CMs with ECs. ISO decreased LDH activity following hypoxia/reoxygenation injury. Furthermore, HIF1a shRNA eliminated the protective effect of ISO on CMs, whereas rVEGF the impaired cardioprotective effect of ISO resulting from HIF1a knockdown can be restored by rVEGF. Collectively, the inhibitory effect of HIF1a shRNA on the cardioprotective effect of ISO depends on reduction of VEGF expression as well as VEGF inactivation. Based on our findings and previous data, we proposed the signalling transduction pathway of ISO cardiac preconditioning (Figure 8) . ISO preconditioning activates VEGF in coronary vasculature. 15 VEGF binding to the receptor kinase VEGFR2 triggers multiple transduction pathways, which leads to an increase in p-Akt. Phosphorylated Akt specifically phosphorylates the Serine1177 of eNOS proteins. The p-eNOS proteins catalyse the substrate, L-arginine, to form NO and L-citrulline. NO produced from eNOS in coronary artery endothelium exerts paracrine effects on CMs and produces cytoprotective effects, in addition to vasodilatory effect.
Volatile anaesthetic agents such as ISO, sevoflurane, enflurane, and desflurane are widely used in human and animal cardiac and non-cardiac 16, 48 The present study demonstrates that Akt contributes to the eNOS phosphorylation in ISO cardiac preconditioning. Whether non-Akt kinases are implicated in the phosphorylation of eNOS is not examined. Another limitation is incomplete phosphorylation sites of eNOS by VEGF. Previous studies have indicated that the phosphorylation of Serine114, 116, 615, 633, and 1177 of eNOS proteins elevates the enzyme activity, whereas the phosphorylation of Threonine495 inhibits the activity. 48 Our present study only examined the phosphorylation of Serine1177 in eNOS proteins. Lastly, this study lacks the study of the essential co-factor of eNOS, tetrahydrobiopterin, which is important in the determination of the eNOS product, NO or superoxide. 49 Our previous studies demonstrated that tetrahydrobiopterin levels, eNOS dimerization, and NO production were significantly elevated following ISO preconditioning. 8, 22 Thus, ISO preconditioning not only enhances the phosphorylation of eNOS but improves its dimerization via increasing tetrahydrobiopterin bioavailability. In summary, the present investigation demonstrates that endothelialmyocardial interaction is involved in the cardioprotective effect of ISO. VEGF in ECs plays an important role in ISO-induced cardioprotection against I/R injury. In the signal transduction pathway of ISO-induced LDH activity in media released from co-cultured ECs and CMs. All cells were subjected to 2 h of hypoxia followed by 2 h of reoxygenation (CON); whereas the cells in normoxia group underwent all culture procedures without hypoxia/reoxygenation. The values of the control groups were arbitrarily defined as one in each batch of experiments. Data are presented as mean ± SEM. Kruskal-Wallis test followed by Dunn's test was used to analyse multiple group comparisons. *P < 0.05 vs. normoxia; † P < 0.05 vs. CON; ‡ P < 0.05 vs. ISO; § P < 0.05 vs. shRNA (n = 6). rVEGF, recombinant vascular growth factor. VEGF regulation of eNOS phosphorylation
